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ABSTRACT 
 
We have reported on utilising digital epiluminescence dermoscopy to detect the sparing of 
perifollicular pigments in localised vitiligo. These spotty zones might be the most acute autoimmune 
battle line. 
We saw a 68-year-old gentleman with five-year history of segmental/generalised vitiligo. He 
declined systemic treatments. These spotty zones mentioned above were identified by 
epiluminescence dermoscopy. We advised him to apply a very potent topical corticosteroid two 
times per week to these zones.  Much improvement was seen in two months.  Complete remission 
was achieved in another two months. 
We discussed on the roles of epiluminescence dermoscopy on the diagnosis and treatments of 
patients with all types of vitiligo where the perifollicular pigment sparing zones were too small to be 
identifiable by naked eyes. 
 
 
Keywords: Depigmentation; hypopigmentation; interfollicular; perifollicular. 
Short Research Article 
 
 
 
 
Chuh; IJTDH, 23(4): 1-7, 2017; Article no.IJTDH.34381 
 
 
 
2 
 
ABBREVIATIONS 
 
GV : Generalised Vitiligo 
DED : Digital Epiluminescence Dermoscopy 
QOL : Quality of Life 
 
1. INTRODUCTION 
 
Generalised vitiligo (GV) is a disfiguring disease 
affecting the self image, daily life, and many 
social issues of sufferers [1]. We have previously 
reported on the application of digital 
epiluminescence dermoscopy (DED) in detecting 
the sparing of perifollicular pigments in localised 
vitiligo [2]. Such pattern should be the most acute 
autoimmune battle line between involved and 
uninvolved skin.  We report here a patient with 
generalised vitiligo treated by DED-guided topical 
treatment. 
 
2. PATIENT REPORT 
 
A 68-year-old gentleman attended our care for 
five-year-long period of a generalised 
depigmented disease affecting his trunk and four 
extremities. He was suffering from systemic 
hypertension on an angiotensin receptor blocker, 
diabetes mellitus on oral hypoglycaemic agents, 
and dyslipoproteinaemia on a statin.  He was an 
ex-smoker having ceased five years ago. He was 
a social drinker. 
 
 
 
Fig. 1a. Segmental/generalised vitiligo in a 
male subject with spotty zones 
 
Examination revealed a band of depigmentation 
running in a transverse orientation on the anterior 
abdominal wall, inferior to the umbilicus (Fig. 1a 
above). One would make a diagnosis of 
segmental vitiligo when the truncal part of Fig. 1a 
was noticed. However, clear inspection would 
reveal depigmented patches on the right hand 
and fingers. 
 
 
 
Fig. 1b. Further depigmented areas with 
sharp and angulated margins in the right 
axilla and right lateral trunk 
 
His scalp, face, and back were relatively devoid 
of patches of depigmentation.  His neck and both 
axillae were involved, with the right axilla shown 
in Fig. 1b above. 
 
The patient volunteered that it was not his truncal 
and axillary lesions that particularly affected his 
self image and quality of life. It was his two 
hands which were troubling him, as depicted in 
Fig. 1c.  He could not shake hands with people in 
this physical appearance. 
 
 
 
Fig. 1c. Depigmented lesions with sharp 
margin on the dorsi of hands, thumbs,  
and fingers 
 
Fig. 1a and 1b also demonstrate the peculiar 
dotted pigments at lesional edges. The 
corresponding dermoscopic appearances were 
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highlighted as Fig. 2a and 2b respectively.  Both 
were taken with high-magnification by digital 
epiluminescence dermoscopy with the level of 
cross-polarisation set to ten (level 1: no cross-
polarisation; level 12: highest cross-polarisation 
for our equipment). 
 
 
 
Fig. 2a. Two patches of pigmented skin in the 
pigmented vs depigmented areas. 
The areas of perifollicular sparing of 
depigmentation are outlined in black 
 
 
 
Fig. 2b. One more example of sparing of 
perifollicular pigments. 
The area of perifollicular sparing of 
depigmentation is outlined in black 
 
There was no laboratory abnormality in his 
routine tests. 
 
The patient declined systemic treatments.  As we 
believe that the system-specific autoimmunity in 
vitiligo should be most active in the zones with 
depigmented interfollicular pigments and spared 
perifollicular pigments, we advised him to apply 
topical corticosteroid to the most active areas of 
the disease.  The dose was 0.05% clobetasol 
propionate (DermovateTM) ointment, to be 
applied twice weekly.  We took several clinical 
photos covering the trunk and limbs of the patient, 
examined him with DED, marked the transitional 
sites on the image files, printed the images, 
handed such to him, and advised him to apply 
the ointment on the sites marked. 
 
We saw the patient every month. Two months 
later, much progress was seen (Fig. 2a – 2b).  
Almost all battlefield lines were reclining from the 
pigmented zones to the dotted zones and to the 
depigmented zones. Improvements for all skin 
areas, shown or not shown in Fig. 3a, 3b and 3c 
were startling. The patient was already feeling 
comfortable to offer handshakes to other people. 
 
The topical corticosteroids were completely 
stopped one month later. Virtually all traces           
of PV were gone then. Unfortunately, clinical 
photos showing complete remission were not 
available. 
 
3. DISCUSSION 
 
Vitiligo – any type concerned – casts significant 
impacts on the quality of life (QOL) of patients [1].  
The presence of lesions on the visible parts and 
the extensiveness of lesions was reported to be 
significantly associated with impairments in QOL 
[3]. Specific scales are now in place to assess 
the impact of vitiligo on the QOL of individual 
patients [4-6]. 
 
Topical and systemic treatments are available for 
vitiligo. Such depends on many factors, not 
necessarily on the percentage of skin surface 
affected per se.  Our patient expressed his wish 
not to embark on systemic treatment.  We thus 
prescribed a potent corticosteroid for him to 
apply twice per week. This was a highly 
important decision to make, catering for the 
efficacy and potential adverse effects of the drug.  
We would like to focus the topical treatment to 
the most active areas of the disease. These sites 
were most likely at the transitional sites with 
sparing of the perifollicular melanocytes. We 
therefore advised the patient to apply the 
fluorinated corticosteroid mainly on these sites. 
 
Applying corticosteroids twice a week is 
unusually low.  We elected to commence on this 
low dosage owing to our experience for other 
patients with marginal or non-marginal vitiligo. 
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Fig. 1a. (For comparison) Segmental/ 
generalised vitiligo in a male subject with 
spotty zones 
 
Fig. 3a. Upon application of highly potent 
topical corticosteroids for two months, 
repigmentation was in definite progress. 
Please compare this with Fig. 1a 
 
  
 
Fig. 1b. (For comparison) Further depigmented 
areas with sharp and angulated margins in the 
right axilla and right lateral trunk 
 
Fig. 3b. Previous lesions of vitiligo on the 
right axilla and right lateral aspect of trunk 
largely remised. Please compare this  
with Fig. 1b 
 
The progress of the patient is clearly shown if 
one compares Fig. 1a and Fig. 3a, Fig. 2a and 
Fig. 3a, and Fig. 1c against Fig. 1c. Yes, there 
existed an element of spontaneous remission by 
the deactivation of the organ-specific-auto-
immunological system of the patient.  However, 
the timing of two months was too short for the re-
pigmentation to be attributed to endogenous 
factors.  We thus postulate, with qualitative 
substantiation, that the remission was related to 
an exogenous factor – topical corticosteroids. 
 
However, the affected body area of the patient 
was extensive.  Having had a highly potent 
corticosteroid prescribed, we harboured a valid 
concern – cutaneous absorption leading to 
adverse effects systemically. This was 
particularly important as he was suffering from 
diabetes mellitus. We therefore advised the 
patient to apply the ointment mainly to the 
transitional zone with sparing of perifollicular 
pigments.  We based this piece of advice on 
biological plausibility. 
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This plausibility rests with the hypothesis that 
there exists two populations of melanocytes – 
perifollicular ones and interfollicular ones. For 
some unknown reasons, the autoimmunity – 
likely to be cell-mediated – invades the 
interfollicular melanocytes first, before attacking 
the perifollicular melanocytes.  In the transitional 
zone, the perifollicular pigments are therefore still 
intact, while the interfollicular pigments are 
already gone [7,8]. This is the underlying 
mechanism for the dotted zone to be seen, and 
why we advised our patient to apply the 
medication to this zone. 
 
We put DED into the picture here for two reasons.  
Firstly, for some patients with early or focal 
vitiligo, the presence of such perifollicular sparing 
pattern cannot be appreciated by naked eyes.  
DED would then be applied to confirm or to 
refute a diagnosis of vitiligo [2].
 
 
Secondly, while the perifollicular pigment-sparing 
dots were largely visible by the naked eyes for 
this patient, this is not the case for many other 
patients. In these circumstances, we could 
perform DED, mark such by skin pencils, take 
and print clinical photos, then release the patient 
home to apply corticosteroids accordingly. Fig. 4 
depicts the back of a patient with GV, with 
perifollicular sparing configuration largely 
invisible to the naked eyes. These areas were 
detected by DED (on the upper parts of the 
lesion) and annotated by dark ovals. 
 
Dermoscopy is increasing being applied to 
diagnose and assess skin diseases other than 
melanomas or other malignant diseases.  It has 
been reported that dermoscopy increases the 
efficacies in diagnosing common inflammatory 
diseases including plaque psoriasis, [9,10] lichen 
planus (Lopez), [9] pityriasis rosea, [10,11] and 
lichen planus [10]. Dermatoscope has also been 
reported to be applicable in diagnosing vascular 
and infectious diseases [12]. We have previously 
reported the first applications of DED to assist in 
the diagnosis of pityriasis rosea, [11] 
pseudofolliculitis, [13] condyloma acuminata, [14] 
pediculosis pubis, [15] and pearly penile papules 
[16]. However, these reports only covered the 
application of DED for diagnostic purposes.  For 
this report, the use of DED directly assisted the 
treatment of the patient. Currently, we have 
already been performing DED-guided micro-
surgeries, and hope to be able to report such in 
the not too distant future. 
 
  
 
Fig. 1c. (For comparison) Depigmented  
lesions with sharp margin on the  
dorsi of hands, thumbs,  
and fingers 
 
Fig. 3c. To the patient with generalised 
vitiligo, disease remission was most 
pertinent on his hands, thumbs, and 
fingers as he could not have a handshake 
with other people. Please compare this 
with Fig. 1c 
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Fig. 4. The back of another patient with generalised vitiligo. Only epiluminescence 
dermoscopy can locate the zones of perifollicular sparing of depigmentation. These areas 
were detected by digital epiluminescence dermoscopy (on the upper parts of the lesion), and 
annotated by dark ovals 
 
4. CONCLUSION 
 
DED-guided topical treatment for GV seems to 
be effective for a patient with generalised vitiligo.  
This treatment method might be particularly 
beneficial for patients with small perifollicular 
pigment-sparing zones. Further studies including 
randomised controlled trials would be necessary 
to confirm the efficacy of this approach. 
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